Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In a new Oxford Science Blog, Charvy Narain (Communications & Public Engagement Manager, Radcliffe Department of Medicine) talks to some of the Oxford University researchers coming together to fight the novel Coronavirus outbreak.

2019-nCov novel coronavirus microscope close up concept

What do a mathematician, an epidemiologist, a vaccine developer, a protein crystallographer and a whole bevy of immunologists and infectious disease specialists have in common? Answer: they’re just some of the Oxford University researchers coming together to fight the novel Coronavirus outbreak which has (to date) killed more than 1,350 people across the globe, with over 60,000 people infected.

The outbreak, which the World Health Organisation has now declared a global health emergency, is caused by a new type of an old foe: coronaviruses are common enough to be one of the causes of the common cold. But they can cause a range of respiratory symptoms from mild to serious – it was a coronavirus that was responsible for the 2002-2004 outbreak of the severe acute respiratory syndrome (SARS), though the novel coronavirus (until recently known as 2019-nCoV, though now dubbed SARS-CoV-2) has already outstripped the SARS death toll in the three months since it has been active.

Like the SARS virus, which was traced back to civet cats, this previously undescribed SARS-CoV-2 is also likely to have been transmitted from an animal to humans – most people in the first cluster of cases worked at or were frequent visitors to one single seafood market in Wuhan in China. But it is now clear that SARS-CoV-2 can be also transferred from an infected person to another person, and these human-to-human transmissions are how the outbreak is currently spreading.

Read the full Oxford Science Blog on the University of Oxford website

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Medical Sciences Division receives REF 2021 results

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.